![Cheryl Gault](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Cheryl Gault
Directeur des opérations chez
RAPPORT THERAPEUTICS, INC.
Fortune : 6 M $ au 31/05/2026
Profil
Cheryl Gault is currently Chief Operating Officer at Rapport Therapeutics, Inc. since 2023.
Formerly, Ms. Gault was Chief Operating Officer at Cyclerion Therapeutics, Inc. from 2021 to 2023, VP-Commercial Strategy & New Product Planning at Ironwood Pharmaceuticals, Inc. from 2017 to 2019, and held the position Head-Sales & Marketing at Genzyme Corp.
Education includes undergraduate studies at Boston College.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 30/03/2026 | 159 914 ( 0,33% ) | 6 M $ | 31/05/2026 |
Postes actifs de Cheryl Gault
| Sociétés | Poste | Début |
|---|---|---|
| RAPPORT THERAPEUTICS, INC. | Directeur des opérations | 07/09/2023 |
Anciens postes connus de Cheryl Gault
| Sociétés | Poste | Fin |
|---|---|---|
| CYCLERION THERAPEUTICS, INC. | Directeur des opérations | 28/07/2023 |
| IRONWOOD PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01/04/2019 |
Genzyme Corp.
 Genzyme Corp. Pharmaceuticals: MajorHealth Technology Develops and manufactures therapies for rare diseases, multiple sclerosis, immunology & oncology | Sales & Marketing | - |
Formation de Cheryl Gault
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
33
Relations au 1er degré
5
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 5 |
|---|---|
Genzyme Corp.
Genzyme Corp. Pharmaceuticals: MajorHealth Technology Develops and manufactures therapies for rare diseases, multiple sclerosis, immunology & oncology | Health Technology |
Ironwood Pharmaceuticals, Inc.
 Ironwood Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops, manufactures and markets gastrointestinal products | Health Technology |
Boston College
 Boston College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Cyclerion Therapeutics, Inc.
 Cyclerion Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and distributes pharmaceutical products for serious and orphan diseases | Health Technology |
Rapport Therapeutics, Inc.
 Rapport Therapeutics, Inc. BiotechnologyHealth Technology Operates as an clinical-stage biotechnology company that engages in discovery and development of medicines for neurological disorder | Health Technology |
